|
1
|
Avesson L and Barry G: The emerging role
of RNA and DNA editing in cancer. Biochim Biophys Acta.
1845:308–316. 2014.PubMed/NCBI
|
|
2
|
Kuong KJ and Loeb LA: APOBEC3B mutagenesis
in cancer. Nat Genet. 45:964–965. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Benne R, Van den Burg J, Brakenhoff JP,
Sloof P, Van Boom JH and Tromp MC: Major transcript of the
frameshifted coxII gene from trypanosome mitochondria contains four
nucleotides that are not encoded in the DNA. Cell. 46:819–826.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burns MB, Lackey L, Carpenter MA, Rathore
A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N,
Nikas JB, et al: APOBEC3B is an enzymatic source of mutation in
breast cancer. Nature. 494:366–370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burns MB, Temiz NA and Harris RS: Evidence
for APOBEC3B in multiple human cancers. Nat Genet. 45:977–983.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lada AG, Dhar A, Boissy RJ, Hirano M,
Rubel AA, Rogozin IB and Pavlov YI: AID/APOBEC cytosine deaminase
induces genome-wide kataegis. Biol Direct. 7:472012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taylor BJ, Nik-Zainal S, Wu YL, Stebbings
LA, Raine K, Campbell PJ, Rada C, Stratton MR and Neuberger MS: DNA
deaminases induce break-associated mutation showers with
implication of APOBEC3B and 3A in breast cancer kataegis. ELife.
2:e005342013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roberts SA, Lawrence MS, Klimczak LJ,
Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL,
Saksena G, et al: An APOBEC cytadine deaminase pattern is
widespread in human cancers. Nat Genet. 45:970–976. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okuyama S, Marusawa H, Matsumoto T, Ueda
Y, Matsumoto Y, Endo Y, Takai A and Chiba T: Excessive activity of
Apolipoprotein B mRNA editing enzyme catalytic polypeptide 2
(APOBEC2) contributes to liver and lung tumorigenesis. Int J
Cancer. 130:1294–1301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jia P, Pao W and Zhao Z: Patterns and
processes of somatic mutations in nine major cancers. BMC Med
Genomics. 7:112014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goutagny S, Yang HW, Zuchman-Rossi J, Chan
J, Dreyfuss JM, Park PJ, Black PM, Giovanni M, Carroll RS and
Kalamarides M: Genomic profiling reveals alternative genetic
pathways of meningioma malignant progression dependent on the
underlying NF2 status. Clin Cancer Res. 16:4155–4164. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perry A, Louis DN, Scheithauer BW, Budka H
and von Deimling A: MeningiomasTumours of the Nervous System. Louis
DN, Ohgaki H, Wiestler OD and Cavenee WK: WHO Press; Geneva,
Switzerland: pp. 164–172. 2007
|
|
13
|
Johnson MD, O'Connell M, Facik M, Maurer
P, Jahromi B and Pilcher W: Cerebrospinal fluid stimulates
leptomeningeal and meningioma cell proliferation and activation of
STAT3. J Neurooncol. 107:121–131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leonard B, Hart SN, Burns MB, Carpenter
MA, Temiz NA, Rathore A, Vogel RI, Nikas JB, Law EK, Brown WL, et
al: APOBEC3B upregulation and genomic mutation patterns in serous
ovarian carcinoma. Cancer Res. 73:7222–7231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sasaki H, Suzuki A, Tatematsu T, Shitara
M, Hikosaka Y, Okuda K, Moriyama S, Yano M and Fujii Y: APOBEC3B
gene overexpression in non-small-cell lung cancer. Biomed Rep.
2:392–395. 2014.PubMed/NCBI
|
|
17
|
Shinohara M, Io K, Shindo K, Matsui M,
Sakamoto T, Tada K, Kobayashi M, Kadowaki N and Takaori-Kondo A:
APOBEC3B can impair genomic stability by inducing base
substitutions in genomic DNA in human cells. Sci Rep. 2:8062012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rebhandal S, Huemer M, Gassner FJ,
Zaborsky N, Hebenstreit D, Catakovic K, Grössinger EM, Greil R and
Geisberger R: APOBEC3 signature mutations in in chronic lymphocytic
leukemia. Leukemia. 28:1929–1932. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Avesson L and Barry G: The emerging role
of RNA and DNA editing in cancer. Biochim and Biophys Acta.
1845:308–316. 2014.
|
